The success of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in the treatment of hematological malignancies remains hampered by life-threatening chronic graft vs. host disease (cGVHD). Although multifactorial in nature, cGVHD has been associated with imbalances between effector and regulatory T cells (Treg). To further elucidate this issue, we performed a prospective analysis of patients undergoing unrelated donor allo-HSCT after a reduced intensity conditioning (RIC) regimen containing anti-thymocyte globulin (ATG) and the same GVHD prophylaxis, at a single institution. We studied T cell subset homeostasis over a 24-month follow-up after HSCT in a comparative analysis of patients with and without cGVHD. We also quantified ...
The critical balance between intended and adverse effects in allogeneic hematopoietic stem cell tran...
Spectratyping assays are well recognized as the clinical gold standard for assessing the T cell rece...
Background: CD3+CD4-CD8- double negative (DN) T cells, as a distinct subset of regulatory T cells (T...
This project received funding from: Fundacão para a Ciência e Tecnologia, Portugal under the Harvard...
© 2016 by The American Society of HematologyThe development and maintenance of immune tolerance afte...
Allogeneic hematopoietic stem cell transplantation (HSCT) is one of curative treatment options for p...
Rapid immune reconstitution (IR) following stem cell transplantation (SCT) is essential for a favora...
<p>The incidence of chronic graft-versus-host disease (cGVHD) is on the rise and still the major cau...
Copyright © 2019 Soares, Azevedo, Ferreira, Bucar, Ribeiro, Vieira, Pereira, Ribeiro, Ligeiro, Alho,...
Allogeneic hematopoietic cell transplantation (allo-HCT) is frequently used as treatment for patient...
γδ T cells perform antitumor and antiviral effector functions and are involved in both innate and ad...
Allogeneic haematopoietic stem cell transplantation (alloHSCT) is an established therapy for many ha...
The study was aimed to analyze the difference of naive and memory CD4(+) and CD8(+) T-cell subsets b...
The critical balance between intended and adverse effects in allogeneic hematopoietic stem cell tran...
The critical balance between intended and adverse effects in allogeneic hematopoietic stem cell tran...
The critical balance between intended and adverse effects in allogeneic hematopoietic stem cell tran...
Spectratyping assays are well recognized as the clinical gold standard for assessing the T cell rece...
Background: CD3+CD4-CD8- double negative (DN) T cells, as a distinct subset of regulatory T cells (T...
This project received funding from: Fundacão para a Ciência e Tecnologia, Portugal under the Harvard...
© 2016 by The American Society of HematologyThe development and maintenance of immune tolerance afte...
Allogeneic hematopoietic stem cell transplantation (HSCT) is one of curative treatment options for p...
Rapid immune reconstitution (IR) following stem cell transplantation (SCT) is essential for a favora...
<p>The incidence of chronic graft-versus-host disease (cGVHD) is on the rise and still the major cau...
Copyright © 2019 Soares, Azevedo, Ferreira, Bucar, Ribeiro, Vieira, Pereira, Ribeiro, Ligeiro, Alho,...
Allogeneic hematopoietic cell transplantation (allo-HCT) is frequently used as treatment for patient...
γδ T cells perform antitumor and antiviral effector functions and are involved in both innate and ad...
Allogeneic haematopoietic stem cell transplantation (alloHSCT) is an established therapy for many ha...
The study was aimed to analyze the difference of naive and memory CD4(+) and CD8(+) T-cell subsets b...
The critical balance between intended and adverse effects in allogeneic hematopoietic stem cell tran...
The critical balance between intended and adverse effects in allogeneic hematopoietic stem cell tran...
The critical balance between intended and adverse effects in allogeneic hematopoietic stem cell tran...
Spectratyping assays are well recognized as the clinical gold standard for assessing the T cell rece...
Background: CD3+CD4-CD8- double negative (DN) T cells, as a distinct subset of regulatory T cells (T...